[ACRX] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
09-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 0.35%
YoY- -14.13%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 1,368 608 377 1,487 3,366 15,428 4,825 -18.93%
PBT -8,930 -12,731 -12,458 -13,013 -11,438 5,841 671 -
Tax 931 1,212 -2,601 -3,233 -36 772 6,556 -27.74%
NP -8,930 -12,731 -12,458 -13,013 -11,402 5,069 671 -
Tax Rate - - - - - -13.22% -977.05% -
Total Cost 10,298 13,339 12,835 14,500 14,768 10,359 4,154 16.32%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -652.78 -2,093.91 -3,304.51 -875.12 -338.74 32.86 13.91 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -2.03 -3.20 -4.15 -5.61 -5.03 2.20 0.40 -
EPS Diluted -2.03 -3.20 -4.15 -5.61 -5.03 2.20 -2.60 -4.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.